thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

COVID Vaccines

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By
NewsFacts Bureau

COVAXIN production to be demand-driven, says Bharat Biotech

By
TheNewsFacts

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

By
TheNewsFacts

Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023

By
TheNewsFacts
Hepatitis

How India Is Building Its Biggest Defence Against Hepatitis

By
SK Panicker
July 27, 2026
Jana Nayagan Review

Jana Nayagan Review: A Celebration of Vijay More Than Cinema

By
SK Panicker
July 25, 2026
Adarsh Baal Vidyalaya Review

Adarsh Baal Vidyalaya Review: Kay Kay Menon Turns a Broken School Into a Winning Comedy

By
SK Panicker
July 24, 2026
Prabhas Fauzi

Prabhas Brings Grit Over Glamour in Fauzi’s Striking New Poster

By
TheNewsFacts
July 16, 2026

Latest Articles

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

By
TheNewsFacts
Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

By
TheNewsFacts
Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

By
TheNewsFacts
New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

By
TheNewsFacts
COVAXIN Latest Peer Review Shows robust safety, immunogenicity in 2-18 years Old

COVAXIN is Safe, Highly Immunogenic in 2-18 Years Old – The Lancet Review

By
TheNewsFacts
Covaxin booster can defend new variants of concern: ICMR Study

COVAXIN booster can defend new variants of concern: ICMR Study

By
TheNewsFacts
Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

By
TheNewsFacts
India Approves COVAXIN for Children 6 to 12 Years Age

India Approves COVAXIN for Children 6 to 12 Years Age

By
TheNewsFacts
1 2 3 4 … 8 9
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?